Literature DB >> 21287696

Prostate cancer: A rocky road to overcoming castration resistance.

Suzanne J Farley.   

Abstract

Entities:  

Year:  2011        PMID： 21287696     DOI： 10.1038/nrurol.2010.211

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Final safety and efficacy analysis of the specific endothelin A receptor antagonist zibotentan (ZD4054) in patients with metastatic castration-resistant prostate cancer and bone metastases who were pain-free or mildly symptomatic for pain: a double-blind, placebo-controlled, randomized Phase II trial.

Authors:  Nicholas D James; Armelle Caty; Heather Payne; Michael Borre; Bernard A Zonnenberg; Philippe Beuzeboc; Stuart McIntosh; Thomas Morris; De Phung; Nancy A Dawson
Journal:  BJU Int       Date:  2010-10       Impact factor: 5.588
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.